EDP Sciences logo
Soumettre un article
rechercher
Menu
Accueil Tous les numéros Volume 18 / Numéro 5 (Septembre-Octobre 2011) OCL, 18 5 (2011) 271-278 Références
Open Access
Numéro
OCL
Volume 18, Numéro 5, Septembre-Octobre 2011
Lipids and Brain II. Actes des Journées Chevreul 2011 (Deuxième partie)
Page(s) 271 - 278
Section PUFA and Neuroprotection
DOI https://doi.org/10.1051/ocl.2011.0389
Publié en ligne 15 septembre 2011
  • Allen CL, Bayraktutan U. Risk factors for ischaemic stroke. Int J Stroke 2008; 3: 105–16. [CrossRef] [PubMed] [Google Scholar]
  • Bas O, Songur A, Sahin O, et al. The protective effect of fish n-3 fatty acids on cerebral ischemia in rat hippocampus. Neurochem Int 2007; 50: 548–54. [CrossRef] [PubMed] [Google Scholar]
  • Blondeau N, Lauritzen I, Widmann C, Lazdunski M, Heurteaux C. A potent protective role of lysophospholipids against global cerebral ischemia and glutamate excitotoxicity in neuronal cultures. J Cereb Blood Flow Metab 2002a; 22: 821–34. [Google Scholar]
  • Blondeau N, Nguemeni C, Debruyne DN, et al. Subchronic alpha-linolenic acid treatment enhances brain plasticity and exerts an antidepressant effect: a versatile potential therapy for stroke. Neuropsychopharmacology 2009; 34: 2548–59. [CrossRef] [PubMed] [Google Scholar]
  • Blondeau N, Petrault O, Manta S, et al. Polyunsaturated fatty acids are cerebral vasodilators via the TREK-1 potassium channel. Circ Res 2007; 101: 176–84. [CrossRef] [PubMed] [Google Scholar]
  • Blondeau N, Plamondon H, Richelme C, Heurteaux C, Lazdunski M. K(ATP) channel openers, adenosine agonists and epileptic preconditioning are stress signals inducing hippocampal neuroprotection. Neuroscience 2000; 100: 465–74. [CrossRef] [PubMed] [Google Scholar]
  • Blondeau N, Widmann C, Lazdunski M, Heurteaux C. Activation of the nuclear factor-kappaB is a key event in brain tolerance. J Neurosci 2001; 21: 4668–77. [PubMed] [Google Scholar]
  • Blondeau N, Widmann C, Lazdunski M, Heurteaux C. Polyunsaturated fatty acids induce ischemic and epileptic tolerance. Neuroscience 2002b; 109: 231–41. [Google Scholar]
  • Dauchet L, Amouyel P, Dallongeville J. Fruit and vegetable consumption and risk of stroke: a meta-analysis of cohort studies. Neurology 2005; 65: 1193–7. [CrossRef] [PubMed] [Google Scholar]
  • de Goede J, Verschuren WM, Boer JM, Kromhout D, Geleijnse JM. Alpha-linolenic Acid intake and 10-year incidence of coronary heart disease and stroke in 20,000 middle-aged men and women in the Netherlands. PLoS One 2011; 6: e17967. [CrossRef] [PubMed] [Google Scholar]
  • Dirnagl U, Simon RP, Hallenbeck JM. Ischemic tolerance and endogenous neuroprotection. Trends Neurosci 2003; 26: 248–54. [CrossRef] [PubMed] [Google Scholar]
  • Endres M, Dirnagl U. Ischemia and stroke. Adv Exp Med Biol 2002; 513: 455–73. [CrossRef] [PubMed] [Google Scholar]
  • Fink M, Lesage F, Duprat F, et al. A neuronal two P domain K+ channel stimulated by arachidonic acid and polyunsaturated fatty acids. EMBO J 1998; 17: 3297–308. [CrossRef] [PubMed] [Google Scholar]
  • Gidday JM. Cerebral preconditioning and ischaemic tolerance. Nat Rev Neurosci 2006; 7: 437–48. [CrossRef] [PubMed] [Google Scholar]
  • Heurteaux C, Laigle C, Blondeau N, Jarretou G, Lazdunski M. Alpha-linolenic acid and riluzole treatment confer cerebral protection and improve survival after focal brain ischemia. Neuroscience 2006; 137: 241–51. [CrossRef] [PubMed] [Google Scholar]
  • Iadecola C. Neurovascular regulation in the normal brain and in Alzheimer’s disease. Nat Rev Neurosci 2004; 5: 347–60. [CrossRef] [PubMed] [Google Scholar]
  • Jonas S, Ayigari V, Viera D, Waterman P. Neuroprotection against cerebral ischemia. A review of animal studies and correlation with human trial results. Ann N Y Acad Sci 1999; 890: 2–3. [CrossRef] [PubMed] [Google Scholar]
  • Kirino T. Ischemic tolerance. J Cereb Blood Flow Metab 2002; 22: 1283–96. [CrossRef] [PubMed] [Google Scholar]
  • Kitagawa K, Matsumoto M, Tagaya M, et al. ‘Ischemic tolerance’ phenomenon found in the brain. Brain Res 1990; 528: 21–4. [CrossRef] [PubMed] [Google Scholar]
  • Lauritzen I, Blondeau N, Heurteaux C, Widmann C, Romey G, Lazdunski M. Polyunsaturated fatty acids are potent neuroprotectors. EMBO J 2000; 19: 1784–93. [CrossRef] [PubMed] [Google Scholar]
  • Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics–2010 update: a report from the American Heart Association. Circulation 2010; 121: e46–e215. [CrossRef] [PubMed] [Google Scholar]
  • Lo EH. Experimental models, neurovascular mechanisms and translational issues in stroke research. Br J Pharmacol 2008; 153 (Suppl. 1): S396–405. [CrossRef] [PubMed] [Google Scholar]
  • Lo EH, Rosenberg GA. The neurovascular unit in health and disease: introduction. Stroke 2009; 40: S2–3. [CrossRef] [PubMed] [Google Scholar]
  • Minnerup J, Schabitz WR. Multifunctional actions of approved and candidate stroke drugs. Neurotherapeutics 2009; 6: 43–52. [CrossRef] [PubMed] [Google Scholar]
  • Moskowitz MA, Lo EH, Iadecola C. The science of stroke: mechanisms in search of treatments. Neuron 2010; 67: 181–98. [CrossRef] [PubMed] [Google Scholar]
  • Nguemeni C, Delplanque B, Rovere C, et al. Dietary supplementation of alpha-linolenic acid in an enriched rapeseed oil diet protects from stroke. Pharmacol Res 2010; 61: 226–33. [CrossRef] [PubMed] [Google Scholar]
  • O’Duffy AE, Bordelon YM, McLaughlin B. Killer proteases and little strokes–how the things that do not kill you make you stronger. J Cereb Blood Flow Metab 2007; 27: 655–68. [PubMed] [Google Scholar]
  • Obrenovitch TP. Molecular physiology of preconditioning-induced brain tolerance to ischemia. Physiol Rev 2008; 88: 211–47. [CrossRef] [PubMed] [Google Scholar]
  • Ozen OA, Cosar M, Sahin O, et al. The protective effect of fish n-3 fatty acids on cerebral ischemia in rat prefrontal cortex. Neurol Sci 2008; 29: 147–52. [CrossRef] [PubMed] [Google Scholar]
  • Plamondon H, Blondeau N, Heurteaux C, Lazdunski M. Mutually protective actions of kainic acid epileptic preconditioning and sublethal global ischemia on hippocampal neuronal death: involvement of adenosine A1 receptors and K(ATP) channels. J Cereb Blood Flow Metab 1999; 19: 1296–308. [CrossRef] [PubMed] [Google Scholar]
  • Pulsinelli WA, Brierley JB. A new model of bilateral hemispheric ischemia in the unanesthetized rat. Stroke 1979; 10: 267–72. [CrossRef] [PubMed] [Google Scholar]
  • Relton JK, Strijbos PJ, Cooper AL, Rothwell NJ. Dietary N-3 fatty acids inhibit ischaemic and excitotoxic brain damage in the rat. Brain Res Bull 1993; 32: 223–6. [CrossRef] [PubMed] [Google Scholar]
  • Riediger ND, Othman RA, Suh M, Moghadasian MH. A systemic review of the roles of n-3 fatty acids in health and disease. J Am Diet Assoc 2009; 109: 668–79. [CrossRef] [PubMed] [Google Scholar]
  • Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics–2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008; 117: e25–146. [CrossRef] [PubMed] [Google Scholar]
  • Simopoulos AP. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med (Maywood) 2008; 233: 674–88. [CrossRef] [PubMed] [Google Scholar]
  • Tauskela JS, Blondeau N 2009 In: Ischemic Tolerance of the Brain, Research Signpost. Schaller BJ, Ed.; Kerala, India: Research Signpost, 2009: 85–135. [Google Scholar]
  • Weih M, Kallenberg K, Bergk A, et al. Attenuated stroke severity after prodromal TIA: a role for ischemic tolerance in the brain? stroke 1999; 30: 1851–4. [CrossRef] [PubMed] [Google Scholar]
  • Zaleska MM, Mercado ML, Chavez J, Feuerstein GZ, Pangalos MN, Wood A. The development of stroke therapeutics: promising mechanisms and translational challenges. Neuropharmacology 2009; 56: 329–41. [CrossRef] [PubMed] [Google Scholar]
  • Zhang ZG, Chopp M. Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic. Lancet Neurol 2009; 8: 491–500. [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.